Obesity,Is,Associated
Inflammation,Promotes,Progression
ObesityassociatedInflammation,Promotes,MetastaticProgression
ObesityassociatedInflammation,Promotes,Progression
Inflammation,Promotes,MetastaticProgression
Obesity,Causes,LungNeutrophilia
Increase,TranslatesTo,IncreasedBreastCancerMetastasis
Increase,TranslatesIn,GMCSF
Increase,IsIn,LungNeutrophils
Increase,TranslatesTo,BreastCancerMetastasis
Purpose,Affects,ResponseToCorticosteroidTreatment
Obesity,IsAssociatedWith,IncreasedSeverity
Purpose,Affects,ResponseToNasalCorticosteroidTreatment
Affects,ResponseTo,CorticosteroidTreatmentInAsthma
Obesity,Is,Associated
Affects,ResponseTo,NasalCorticosteroidTreatmentInAsthma
Purpose,Affects,Response
Affects,ResponseTo,NasalCorticosteroidTreatment
Purpose,Affects,ResponseToCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfDisease
Obesity,IsAssociatedWith,SeverityOfSinonasalDisease
Obesity,IsAssociatedWith,Severity
NasalCorticosteroidTreatment,IsIn,Asthma
Purpose,Was,Determine
Obesity,IsAssociatedWith,SeverityOfDisease
Affects,ResponseTo,CorticosteroidTreatment
Purpose,Affects,ResponseToNasalCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfSinonasalDisease
WeightLoss,Is,ImportantlySufficient
WeightLoss,Reduce,SerumLevels
WeightLoss,Reduce,SerumLevelsOfGMCSF
WeightLoss,Is,Sufficient
WeightLoss,ReduceSerumLevelsIn,MouseModels
SinonasalDiseaseSymptoms,IsWith,IncreasedAsthmaSeverity
Association,AreConsistentAcross,BMIGroups
Response,Requires,Study
Response,Requires,FurtherStudy
Consideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,Management
SpecialConsideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagement
SpecialConsideration,IsCriticalFor,EffectiveManagementOfCancerProgression
Consideration,IsCriticalFor,Management
SpecialConsideration,IsCriticalFor,ManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,EffectiveManagement
Consideration,IsCriticalFor,ManagementOfCancerProgression
Links,Are,Understood
ThrombinActivity,Underlies,ThromboembolicEvents
ElevatedThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
Links,Are,IncompletelyUnderstood
MechanisticLinks,Are,IncompletelyUnderstood
ElevatedThrombinActivity,Underlies,ThromboembolicEvents
MechanisticLinks,Are,Understood
ThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
DiagnosticCriteria,Should,ShouldDescriptive
Criteria,Should,ShouldDescriptive
Avoid,AttributionOf,Causality
DiagnosticCriteria,Avoid,AttributionOfCausality
Criteria,Avoid,AttributionOfCausality
Wording,Should,ShouldEvidencebased
Wording,Should,FurthermoreShouldEvidencebased
Uncertainties,Direct,FutureResearch
Uncertainties,Direct,FutureClinicalResearch
Uncertainties,May,MayAddressed
Uncertainties,Direct,TheirImplications
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
Studies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDeposits
Studies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsFeatures
Studies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
Studies,Identified,ExtravascularFibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeatures
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsFeatures
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDeposits
Studies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,FibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,FibrinDeposits
Studies,Identified,DepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDeposits
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeatures
Carrying,FormOf,Fibrinogen
Carrying,FormOf,FibrinogenIncapable
Fibγ390396AMice,Were,Protected
Fibγ390396AMice,WereProtectedFrom,WeightGain
Carrying,MutantFormOf,FibrinogenIncapable
Fibγ390396AMice,WereProtectedFrom,HFDinducedWeightGain
Carrying,MutantFormOf,Fibrinogen
Fibγ390396AMice,HadDiminished,Systemic
Fibγ390396AMice,HadMarkedlyDiminished,Systemic
HepaticInflammation,IsWith,ReducedMacrophageCountsWithinWhiteAdiposeTissue
DirectThrombinInhibitor,IsWith,EstablishedObesity
Treatment,IsWith,Dabigatran
DirectThrombinInhibitor,IsIn,Mice
Pathologies,IsIn,ObesePatients
Pathologies,Targeting,Thrombin
It,Review,CurrentICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraft
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraft
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItEndeavor,Review,ICD11BetaDraft
It,Review,ICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraft
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfRevision
Patients,IsWith,Obesity
SinonasalDisease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,PoorAsthmaControl
SinonasalDisease,CanContributeTo,PoorAsthmaControl
LinkObesity,IsWith,IncreasedPrevalenceOfSinonasalDisease
Obesity,Is,Associated
Inflammation,Promotes,Progression
ObesityassociatedInflammation,Promotes,MetastaticProgression
ObesityassociatedInflammation,Promotes,Progression
Inflammation,Promotes,MetastaticProgression
Obesity,Causes,LungNeutrophilia
Increase,TranslatesTo,IncreasedBreastCancerMetastasis
Increase,TranslatesIn,GMCSF
Increase,IsIn,LungNeutrophils
Increase,TranslatesTo,BreastCancerMetastasis
Purpose,Affects,ResponseToCorticosteroidTreatment
Obesity,IsAssociatedWith,IncreasedSeverity
Purpose,Affects,ResponseToNasalCorticosteroidTreatment
Affects,ResponseTo,CorticosteroidTreatmentInAsthma
Obesity,Is,Associated
Affects,ResponseTo,NasalCorticosteroidTreatmentInAsthma
Purpose,Affects,Response
Affects,ResponseTo,NasalCorticosteroidTreatment
Purpose,Affects,ResponseToCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfDisease
Obesity,IsAssociatedWith,SeverityOfSinonasalDisease
Obesity,IsAssociatedWith,Severity
NasalCorticosteroidTreatment,IsIn,Asthma
Purpose,Was,Determine
Obesity,IsAssociatedWith,SeverityOfDisease
Affects,ResponseTo,CorticosteroidTreatment
Purpose,Affects,ResponseToNasalCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfSinonasalDisease
WeightLoss,Is,ImportantlySufficient
WeightLoss,Reduce,SerumLevels
WeightLoss,Reduce,SerumLevelsOfGMCSF
WeightLoss,Is,Sufficient
WeightLoss,ReduceSerumLevelsIn,MouseModels
SinonasalDiseaseSymptoms,IsWith,IncreasedAsthmaSeverity
Association,AreConsistentAcross,BMIGroups
Response,Requires,Study
Response,Requires,FurtherStudy
Consideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,Management
SpecialConsideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagement
SpecialConsideration,IsCriticalFor,EffectiveManagementOfCancerProgression
Consideration,IsCriticalFor,Management
SpecialConsideration,IsCriticalFor,ManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,EffectiveManagement
Consideration,IsCriticalFor,ManagementOfCancerProgression
DiagnosticCriteria,Should,ShouldDescriptive
Criteria,Should,ShouldDescriptive
Avoid,AttributionOf,Causality
DiagnosticCriteria,Avoid,AttributionOfCausality
Criteria,Avoid,AttributionOfCausality
Links,Are,Understood
ThrombinActivity,Underlies,ThromboembolicEvents
ElevatedThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
Links,Are,IncompletelyUnderstood
MechanisticLinks,Are,IncompletelyUnderstood
ElevatedThrombinActivity,Underlies,ThromboembolicEvents
MechanisticLinks,Are,Understood
ThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
Wording,Should,ShouldEvidencebased
Wording,Should,FurthermoreShouldEvidencebased
Uncertainties,Direct,FutureResearch
Uncertainties,Direct,FutureClinicalResearch
Uncertainties,May,MayAddressed
Uncertainties,Direct,TheirImplications
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
Studies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDeposits
Studies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsFeatures
Studies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
Studies,Identified,ExtravascularFibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeatures
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsFeatures
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDeposits
Studies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,FibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,FibrinDeposits
Studies,Identified,DepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDeposits
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeatures
Carrying,FormOf,Fibrinogen
Carrying,FormOf,FibrinogenIncapable
Fibγ390396AMice,Were,Protected
Fibγ390396AMice,WereProtectedFrom,WeightGain
Carrying,MutantFormOf,FibrinogenIncapable
Fibγ390396AMice,WereProtectedFrom,HFDinducedWeightGain
Carrying,MutantFormOf,Fibrinogen
Fibγ390396AMice,HadDiminished,Systemic
Fibγ390396AMice,HadMarkedlyDiminished,Systemic
HepaticInflammation,IsWith,ReducedMacrophageCountsWithinWhiteAdiposeTissue
DirectThrombinInhibitor,IsWith,EstablishedObesity
Treatment,IsWith,Dabigatran
DirectThrombinInhibitor,IsIn,Mice
Pathologies,IsIn,ObesePatients
Pathologies,Targeting,Thrombin
It,Review,CurrentICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraft
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraft
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItEndeavor,Review,ICD11BetaDraft
It,Review,ICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraft
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfRevision
Patients,IsWith,Obesity
SinonasalDisease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,PoorAsthmaControl
SinonasalDisease,CanContributeTo,PoorAsthmaControl
LinkObesity,IsWith,IncreasedPrevalenceOfSinonasalDisease
Obesity,Is,Associated
Inflammation,Promotes,Progression
ObesityassociatedInflammation,Promotes,MetastaticProgression
ObesityassociatedInflammation,Promotes,Progression
Inflammation,Promotes,MetastaticProgression
Obesity,Causes,LungNeutrophilia
Increase,TranslatesTo,IncreasedBreastCancerMetastasis
Increase,TranslatesIn,GMCSF
Increase,IsIn,LungNeutrophils
Increase,TranslatesTo,BreastCancerMetastasis
Purpose,Affects,ResponseToCorticosteroidTreatment
Obesity,IsAssociatedWith,IncreasedSeverity
Purpose,Affects,ResponseToNasalCorticosteroidTreatment
Affects,ResponseTo,CorticosteroidTreatmentInAsthma
Obesity,Is,Associated
Affects,ResponseTo,NasalCorticosteroidTreatmentInAsthma
Purpose,Affects,Response
Affects,ResponseTo,NasalCorticosteroidTreatment
Purpose,Affects,ResponseToCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfDisease
Obesity,IsAssociatedWith,SeverityOfSinonasalDisease
Obesity,IsAssociatedWith,Severity
NasalCorticosteroidTreatment,IsIn,Asthma
Purpose,Was,Determine
Obesity,IsAssociatedWith,SeverityOfDisease
Affects,ResponseTo,CorticosteroidTreatment
Purpose,Affects,ResponseToNasalCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfSinonasalDisease
WeightLoss,Is,ImportantlySufficient
WeightLoss,Reduce,SerumLevels
WeightLoss,Reduce,SerumLevelsOfGMCSF
WeightLoss,Is,Sufficient
WeightLoss,ReduceSerumLevelsIn,MouseModels
SinonasalDiseaseSymptoms,IsWith,IncreasedAsthmaSeverity
Association,AreConsistentAcross,BMIGroups
Response,Requires,Study
Response,Requires,FurtherStudy
Consideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,Management
SpecialConsideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagement
SpecialConsideration,IsCriticalFor,EffectiveManagementOfCancerProgression
Consideration,IsCriticalFor,Management
SpecialConsideration,IsCriticalFor,ManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,EffectiveManagement
Consideration,IsCriticalFor,ManagementOfCancerProgression
DiagnosticCriteria,Should,ShouldDescriptive
Criteria,Should,ShouldDescriptive
Avoid,AttributionOf,Causality
DiagnosticCriteria,Avoid,AttributionOfCausality
Criteria,Avoid,AttributionOfCausality
Links,Are,Understood
ThrombinActivity,Underlies,ThromboembolicEvents
ElevatedThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
Links,Are,IncompletelyUnderstood
MechanisticLinks,Are,IncompletelyUnderstood
ElevatedThrombinActivity,Underlies,ThromboembolicEvents
MechanisticLinks,Are,Understood
ThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
Wording,Should,ShouldEvidencebased
Wording,Should,FurthermoreShouldEvidencebased
Uncertainties,Direct,FutureResearch
Uncertainties,Direct,FutureClinicalResearch
Uncertainties,May,MayAddressed
Uncertainties,Direct,TheirImplications
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
Studies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDeposits
Studies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsFeatures
Studies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
Studies,Identified,ExtravascularFibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeatures
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsFeatures
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDeposits
Studies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,FibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,FibrinDeposits
Studies,Identified,DepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDeposits
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeatures
Carrying,FormOf,Fibrinogen
Carrying,FormOf,FibrinogenIncapable
Fibγ390396AMice,Were,Protected
Fibγ390396AMice,WereProtectedFrom,WeightGain
Carrying,MutantFormOf,FibrinogenIncapable
Fibγ390396AMice,WereProtectedFrom,HFDinducedWeightGain
Carrying,MutantFormOf,Fibrinogen
Fibγ390396AMice,HadDiminished,Systemic
Fibγ390396AMice,HadMarkedlyDiminished,Systemic
HepaticInflammation,IsWith,ReducedMacrophageCountsWithinWhiteAdiposeTissue
DirectThrombinInhibitor,IsWith,EstablishedObesity
Treatment,IsWith,Dabigatran
DirectThrombinInhibitor,IsIn,Mice
Pathologies,IsIn,ObesePatients
Pathologies,Targeting,Thrombin
It,Review,CurrentICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraft
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraft
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItEndeavor,Review,ICD11BetaDraft
It,Review,ICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraft
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfRevision
Patients,IsWith,Obesity
SinonasalDisease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,PoorAsthmaControl
SinonasalDisease,CanContributeTo,PoorAsthmaControl
LinkObesity,IsWith,IncreasedPrevalenceOfSinonasalDisease
Obesity,Is,Associated
Inflammation,Promotes,Progression
ObesityassociatedInflammation,Promotes,MetastaticProgression
ObesityassociatedInflammation,Promotes,Progression
Inflammation,Promotes,MetastaticProgression
Obesity,Causes,LungNeutrophilia
Purpose,Affects,ResponseToCorticosteroidTreatment
Obesity,IsAssociatedWith,IncreasedSeverity
Purpose,Affects,ResponseToNasalCorticosteroidTreatment
Affects,ResponseTo,CorticosteroidTreatmentInAsthma
Obesity,Is,Associated
Affects,ResponseTo,NasalCorticosteroidTreatmentInAsthma
Purpose,Affects,Response
Affects,ResponseTo,NasalCorticosteroidTreatment
Purpose,Affects,ResponseToCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfDisease
Obesity,IsAssociatedWith,SeverityOfSinonasalDisease
Obesity,IsAssociatedWith,Severity
NasalCorticosteroidTreatment,IsIn,Asthma
Purpose,Was,Determine
Obesity,IsAssociatedWith,SeverityOfDisease
Affects,ResponseTo,CorticosteroidTreatment
Purpose,Affects,ResponseToNasalCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfSinonasalDisease
Increase,TranslatesTo,IncreasedBreastCancerMetastasis
Increase,TranslatesIn,GMCSF
Increase,IsIn,LungNeutrophils
Increase,TranslatesTo,BreastCancerMetastasis
SinonasalDiseaseSymptoms,IsWith,IncreasedAsthmaSeverity
Association,AreConsistentAcross,BMIGroups
Response,Requires,Study
Response,Requires,FurtherStudy
WeightLoss,Is,ImportantlySufficient
WeightLoss,Reduce,SerumLevels
WeightLoss,Reduce,SerumLevelsOfGMCSF
WeightLoss,Is,Sufficient
WeightLoss,ReduceSerumLevelsIn,MouseModels
Links,Are,Understood
ThrombinActivity,Underlies,ThromboembolicEvents
ElevatedThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
Links,Are,IncompletelyUnderstood
MechanisticLinks,Are,IncompletelyUnderstood
ElevatedThrombinActivity,Underlies,ThromboembolicEvents
MechanisticLinks,Are,Understood
ThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
Consideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,Management
SpecialConsideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagement
SpecialConsideration,IsCriticalFor,EffectiveManagementOfCancerProgression
Consideration,IsCriticalFor,Management
SpecialConsideration,IsCriticalFor,ManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,EffectiveManagement
Consideration,IsCriticalFor,ManagementOfCancerProgression
DiagnosticCriteria,Should,ShouldDescriptive
Criteria,Should,ShouldDescriptive
Avoid,AttributionOf,Causality
DiagnosticCriteria,Avoid,AttributionOfCausality
Criteria,Avoid,AttributionOfCausality
Wording,Should,ShouldEvidencebased
Wording,Should,FurthermoreShouldEvidencebased
Uncertainties,Direct,FutureResearch
Uncertainties,Direct,FutureClinicalResearch
Uncertainties,May,MayAddressed
Uncertainties,Direct,TheirImplications
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
Studies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDeposits
Studies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsFeatures
Studies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
Studies,Identified,ExtravascularFibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeatures
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsFeatures
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDeposits
Studies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,FibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,FibrinDeposits
Studies,Identified,DepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDeposits
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeatures
Carrying,FormOf,Fibrinogen
Carrying,FormOf,FibrinogenIncapable
Fibγ390396AMice,Were,Protected
Fibγ390396AMice,WereProtectedFrom,WeightGain
Carrying,MutantFormOf,FibrinogenIncapable
Fibγ390396AMice,WereProtectedFrom,HFDinducedWeightGain
Carrying,MutantFormOf,Fibrinogen
Fibγ390396AMice,HadDiminished,Systemic
Fibγ390396AMice,HadMarkedlyDiminished,Systemic
HepaticInflammation,IsWith,ReducedMacrophageCountsWithinWhiteAdiposeTissue
DirectThrombinInhibitor,IsWith,EstablishedObesity
Treatment,IsWith,Dabigatran
DirectThrombinInhibitor,IsIn,Mice
Pathologies,IsIn,ObesePatients
Pathologies,Targeting,Thrombin
It,Review,CurrentICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraft
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraft
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItEndeavor,Review,ICD11BetaDraft
It,Review,ICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraft
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfRevision
Patients,IsWith,Obesity
SinonasalDisease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,PoorAsthmaControl
SinonasalDisease,CanContributeTo,PoorAsthmaControl
LinkObesity,IsWith,IncreasedPrevalenceOfSinonasalDisease
Obesity,Is,Associated
Inflammation,Promotes,Progression
ObesityassociatedInflammation,Promotes,MetastaticProgression
ObesityassociatedInflammation,Promotes,Progression
Inflammation,Promotes,MetastaticProgression
Obesity,Causes,LungNeutrophilia
Increase,TranslatesTo,IncreasedBreastCancerMetastasis
Increase,TranslatesIn,GMCSF
Increase,IsIn,LungNeutrophils
Increase,TranslatesTo,BreastCancerMetastasis
Purpose,Affects,ResponseToCorticosteroidTreatment
Obesity,IsAssociatedWith,IncreasedSeverity
Purpose,Affects,ResponseToNasalCorticosteroidTreatment
Affects,ResponseTo,CorticosteroidTreatmentInAsthma
Obesity,Is,Associated
Affects,ResponseTo,NasalCorticosteroidTreatmentInAsthma
Purpose,Affects,Response
Affects,ResponseTo,NasalCorticosteroidTreatment
Purpose,Affects,ResponseToCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfDisease
Obesity,IsAssociatedWith,SeverityOfSinonasalDisease
Obesity,IsAssociatedWith,Severity
NasalCorticosteroidTreatment,IsIn,Asthma
Purpose,Was,Determine
Obesity,IsAssociatedWith,SeverityOfDisease
Affects,ResponseTo,CorticosteroidTreatment
Purpose,Affects,ResponseToNasalCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfSinonasalDisease
SinonasalDiseaseSymptoms,IsWith,IncreasedAsthmaSeverity
Association,AreConsistentAcross,BMIGroups
WeightLoss,Is,ImportantlySufficient
WeightLoss,Reduce,SerumLevels
WeightLoss,Reduce,SerumLevelsOfGMCSF
WeightLoss,Is,Sufficient
WeightLoss,ReduceSerumLevelsIn,MouseModels
Response,Requires,Study
Response,Requires,FurtherStudy
Consideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,Management
SpecialConsideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagement
SpecialConsideration,IsCriticalFor,EffectiveManagementOfCancerProgression
Consideration,IsCriticalFor,Management
SpecialConsideration,IsCriticalFor,ManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,EffectiveManagement
Consideration,IsCriticalFor,ManagementOfCancerProgression
Links,Are,Understood
ThrombinActivity,Underlies,ThromboembolicEvents
ElevatedThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
Links,Are,IncompletelyUnderstood
MechanisticLinks,Are,IncompletelyUnderstood
ElevatedThrombinActivity,Underlies,ThromboembolicEvents
MechanisticLinks,Are,Understood
ThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
DiagnosticCriteria,Should,ShouldDescriptive
Criteria,Should,ShouldDescriptive
Avoid,AttributionOf,Causality
DiagnosticCriteria,Avoid,AttributionOfCausality
Criteria,Avoid,AttributionOfCausality
Wording,Should,ShouldEvidencebased
Wording,Should,FurthermoreShouldEvidencebased
Uncertainties,Direct,FutureResearch
Uncertainties,Direct,FutureClinicalResearch
Uncertainties,May,MayAddressed
Uncertainties,Direct,TheirImplications
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
Studies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDeposits
Studies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsFeatures
Studies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
Studies,Identified,ExtravascularFibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeatures
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsFeatures
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDeposits
Studies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,FibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,FibrinDeposits
Studies,Identified,DepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDeposits
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeatures
Carrying,FormOf,Fibrinogen
Carrying,FormOf,FibrinogenIncapable
Fibγ390396AMice,Were,Protected
Fibγ390396AMice,WereProtectedFrom,WeightGain
Carrying,MutantFormOf,FibrinogenIncapable
Fibγ390396AMice,WereProtectedFrom,HFDinducedWeightGain
Carrying,MutantFormOf,Fibrinogen
Fibγ390396AMice,HadDiminished,Systemic
Fibγ390396AMice,HadMarkedlyDiminished,Systemic
HepaticInflammation,IsWith,ReducedMacrophageCountsWithinWhiteAdiposeTissue
DirectThrombinInhibitor,IsWith,EstablishedObesity
Treatment,IsWith,Dabigatran
DirectThrombinInhibitor,IsIn,Mice
Pathologies,IsIn,ObesePatients
Pathologies,Targeting,Thrombin
It,Review,CurrentICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraft
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraft
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItEndeavor,Review,ICD11BetaDraft
It,Review,ICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraft
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfRevision
Patients,IsWith,Obesity
SinonasalDisease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,PoorAsthmaControl
SinonasalDisease,CanContributeTo,PoorAsthmaControl
LinkObesity,IsWith,IncreasedPrevalenceOfSinonasalDisease
Obesity,Is,Associated
Inflammation,Promotes,Progression
ObesityassociatedInflammation,Promotes,MetastaticProgression
ObesityassociatedInflammation,Promotes,Progression
Inflammation,Promotes,MetastaticProgression
Obesity,Causes,LungNeutrophilia
Increase,TranslatesTo,IncreasedBreastCancerMetastasis
Increase,TranslatesIn,GMCSF
Increase,IsIn,LungNeutrophils
Increase,TranslatesTo,BreastCancerMetastasis
Purpose,Affects,ResponseToCorticosteroidTreatment
Obesity,IsAssociatedWith,IncreasedSeverity
Purpose,Affects,ResponseToNasalCorticosteroidTreatment
Affects,ResponseTo,CorticosteroidTreatmentInAsthma
Obesity,Is,Associated
Affects,ResponseTo,NasalCorticosteroidTreatmentInAsthma
Purpose,Affects,Response
Affects,ResponseTo,NasalCorticosteroidTreatment
Purpose,Affects,ResponseToCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfDisease
Obesity,IsAssociatedWith,SeverityOfSinonasalDisease
Obesity,IsAssociatedWith,Severity
NasalCorticosteroidTreatment,IsIn,Asthma
Purpose,Was,Determine
Obesity,IsAssociatedWith,SeverityOfDisease
Affects,ResponseTo,CorticosteroidTreatment
Purpose,Affects,ResponseToNasalCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfSinonasalDisease
WeightLoss,Is,ImportantlySufficient
WeightLoss,Reduce,SerumLevels
WeightLoss,Reduce,SerumLevelsOfGMCSF
WeightLoss,Is,Sufficient
WeightLoss,ReduceSerumLevelsIn,MouseModels
SinonasalDiseaseSymptoms,IsWith,IncreasedAsthmaSeverity
Association,AreConsistentAcross,BMIGroups
Response,Requires,Study
Response,Requires,FurtherStudy
Consideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,Management
SpecialConsideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagement
SpecialConsideration,IsCriticalFor,EffectiveManagementOfCancerProgression
Consideration,IsCriticalFor,Management
SpecialConsideration,IsCriticalFor,ManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,EffectiveManagement
Consideration,IsCriticalFor,ManagementOfCancerProgression
Links,Are,Understood
ThrombinActivity,Underlies,ThromboembolicEvents
ElevatedThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
Links,Are,IncompletelyUnderstood
MechanisticLinks,Are,IncompletelyUnderstood
ElevatedThrombinActivity,Underlies,ThromboembolicEvents
MechanisticLinks,Are,Understood
ThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
DiagnosticCriteria,Should,ShouldDescriptive
Criteria,Should,ShouldDescriptive
Avoid,AttributionOf,Causality
DiagnosticCriteria,Avoid,AttributionOfCausality
Criteria,Avoid,AttributionOfCausality
Wording,Should,ShouldEvidencebased
Wording,Should,FurthermoreShouldEvidencebased
Uncertainties,Direct,FutureResearch
Uncertainties,Direct,FutureClinicalResearch
Uncertainties,May,MayAddressed
Uncertainties,Direct,TheirImplications
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
Studies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDeposits
Studies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsFeatures
Studies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
Studies,Identified,ExtravascularFibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeatures
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsFeatures
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDeposits
Studies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,FibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,FibrinDeposits
Studies,Identified,DepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDeposits
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeatures
Carrying,FormOf,Fibrinogen
Carrying,FormOf,FibrinogenIncapable
Fibγ390396AMice,Were,Protected
Fibγ390396AMice,WereProtectedFrom,WeightGain
Carrying,MutantFormOf,FibrinogenIncapable
Fibγ390396AMice,WereProtectedFrom,HFDinducedWeightGain
Carrying,MutantFormOf,Fibrinogen
Fibγ390396AMice,HadDiminished,Systemic
Fibγ390396AMice,HadMarkedlyDiminished,Systemic
HepaticInflammation,IsWith,ReducedMacrophageCountsWithinWhiteAdiposeTissue
DirectThrombinInhibitor,IsWith,EstablishedObesity
Treatment,IsWith,Dabigatran
DirectThrombinInhibitor,IsIn,Mice
Pathologies,IsIn,ObesePatients
Pathologies,Targeting,Thrombin
It,Review,CurrentICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraft
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraft
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItEndeavor,Review,ICD11BetaDraft
It,Review,ICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraft
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfRevision
Patients,IsWith,Obesity
SinonasalDisease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,PoorAsthmaControl
SinonasalDisease,CanContributeTo,PoorAsthmaControl
LinkObesity,IsWith,IncreasedPrevalenceOfSinonasalDisease
Obesity,Is,Associated
Inflammation,Promotes,Progression
ObesityassociatedInflammation,Promotes,MetastaticProgression
ObesityassociatedInflammation,Promotes,Progression
Inflammation,Promotes,MetastaticProgression
Obesity,Causes,LungNeutrophilia
Increase,TranslatesTo,IncreasedBreastCancerMetastasis
Increase,TranslatesIn,GMCSF
Increase,IsIn,LungNeutrophils
Increase,TranslatesTo,BreastCancerMetastasis
Purpose,Affects,ResponseToCorticosteroidTreatment
Obesity,IsAssociatedWith,IncreasedSeverity
Purpose,Affects,ResponseToNasalCorticosteroidTreatment
Affects,ResponseTo,CorticosteroidTreatmentInAsthma
Obesity,Is,Associated
Affects,ResponseTo,NasalCorticosteroidTreatmentInAsthma
Purpose,Affects,Response
Affects,ResponseTo,NasalCorticosteroidTreatment
Purpose,Affects,ResponseToCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfDisease
Obesity,IsAssociatedWith,SeverityOfSinonasalDisease
Obesity,IsAssociatedWith,Severity
NasalCorticosteroidTreatment,IsIn,Asthma
Purpose,Was,Determine
Obesity,IsAssociatedWith,SeverityOfDisease
Affects,ResponseTo,CorticosteroidTreatment
Purpose,Affects,ResponseToNasalCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfSinonasalDisease
WeightLoss,Is,ImportantlySufficient
WeightLoss,Reduce,SerumLevels
WeightLoss,Reduce,SerumLevelsOfGMCSF
WeightLoss,Is,Sufficient
WeightLoss,ReduceSerumLevelsIn,MouseModels
SinonasalDiseaseSymptoms,IsWith,IncreasedAsthmaSeverity
Association,AreConsistentAcross,BMIGroups
Response,Requires,Study
Response,Requires,FurtherStudy
Consideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,Management
SpecialConsideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagement
SpecialConsideration,IsCriticalFor,EffectiveManagementOfCancerProgression
Consideration,IsCriticalFor,Management
SpecialConsideration,IsCriticalFor,ManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,EffectiveManagement
Consideration,IsCriticalFor,ManagementOfCancerProgression
Links,Are,Understood
ThrombinActivity,Underlies,ThromboembolicEvents
ElevatedThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
Links,Are,IncompletelyUnderstood
MechanisticLinks,Are,IncompletelyUnderstood
ElevatedThrombinActivity,Underlies,ThromboembolicEvents
MechanisticLinks,Are,Understood
ThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
DiagnosticCriteria,Should,ShouldDescriptive
Criteria,Should,ShouldDescriptive
Avoid,AttributionOf,Causality
DiagnosticCriteria,Avoid,AttributionOfCausality
Criteria,Avoid,AttributionOfCausality
Wording,Should,ShouldEvidencebased
Wording,Should,FurthermoreShouldEvidencebased
Uncertainties,Direct,FutureResearch
Uncertainties,Direct,FutureClinicalResearch
Uncertainties,May,MayAddressed
Uncertainties,Direct,TheirImplications
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
Studies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDeposits
Studies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsFeatures
Studies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
Studies,Identified,ExtravascularFibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeatures
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsFeatures
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDeposits
Studies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,FibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,FibrinDeposits
Studies,Identified,DepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDeposits
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeatures
Carrying,FormOf,Fibrinogen
Carrying,FormOf,FibrinogenIncapable
Fibγ390396AMice,Were,Protected
Fibγ390396AMice,WereProtectedFrom,WeightGain
Carrying,MutantFormOf,FibrinogenIncapable
Fibγ390396AMice,WereProtectedFrom,HFDinducedWeightGain
Carrying,MutantFormOf,Fibrinogen
Fibγ390396AMice,HadDiminished,Systemic
Fibγ390396AMice,HadMarkedlyDiminished,Systemic
HepaticInflammation,IsWith,ReducedMacrophageCountsWithinWhiteAdiposeTissue
DirectThrombinInhibitor,IsWith,EstablishedObesity
Treatment,IsWith,Dabigatran
DirectThrombinInhibitor,IsIn,Mice
Pathologies,IsIn,ObesePatients
Pathologies,Targeting,Thrombin
It,Review,CurrentICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraft
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraft
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItEndeavor,Review,ICD11BetaDraft
It,Review,ICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraft
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfRevision
Patients,IsWith,Obesity
SinonasalDisease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,PoorAsthmaControl
SinonasalDisease,CanContributeTo,PoorAsthmaControl
LinkObesity,IsWith,IncreasedPrevalenceOfSinonasalDisease
Obesity,Is,Associated
Inflammation,Promotes,Progression
ObesityassociatedInflammation,Promotes,MetastaticProgression
ObesityassociatedInflammation,Promotes,Progression
Inflammation,Promotes,MetastaticProgression
Obesity,Causes,LungNeutrophilia
Increase,TranslatesTo,IncreasedBreastCancerMetastasis
Increase,TranslatesIn,GMCSF
Increase,IsIn,LungNeutrophils
Increase,TranslatesTo,BreastCancerMetastasis
Purpose,Affects,ResponseToCorticosteroidTreatment
Obesity,IsAssociatedWith,IncreasedSeverity
Purpose,Affects,ResponseToNasalCorticosteroidTreatment
Affects,ResponseTo,CorticosteroidTreatmentInAsthma
Obesity,Is,Associated
Affects,ResponseTo,NasalCorticosteroidTreatmentInAsthma
Purpose,Affects,Response
Affects,ResponseTo,NasalCorticosteroidTreatment
Purpose,Affects,ResponseToCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfDisease
Obesity,IsAssociatedWith,SeverityOfSinonasalDisease
Obesity,IsAssociatedWith,Severity
NasalCorticosteroidTreatment,IsIn,Asthma
Purpose,Was,Determine
Obesity,IsAssociatedWith,SeverityOfDisease
Affects,ResponseTo,CorticosteroidTreatment
Purpose,Affects,ResponseToNasalCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfSinonasalDisease
SinonasalDiseaseSymptoms,IsWith,IncreasedAsthmaSeverity
Association,AreConsistentAcross,BMIGroups
Response,Requires,Study
Response,Requires,FurtherStudy
WeightLoss,Is,ImportantlySufficient
WeightLoss,Reduce,SerumLevels
WeightLoss,Reduce,SerumLevelsOfGMCSF
WeightLoss,Is,Sufficient
WeightLoss,ReduceSerumLevelsIn,MouseModels
Consideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,Management
SpecialConsideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagement
SpecialConsideration,IsCriticalFor,EffectiveManagementOfCancerProgression
Consideration,IsCriticalFor,Management
SpecialConsideration,IsCriticalFor,ManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,EffectiveManagement
Consideration,IsCriticalFor,ManagementOfCancerProgression
Links,Are,Understood
ThrombinActivity,Underlies,ThromboembolicEvents
ElevatedThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
Links,Are,IncompletelyUnderstood
MechanisticLinks,Are,IncompletelyUnderstood
ElevatedThrombinActivity,Underlies,ThromboembolicEvents
MechanisticLinks,Are,Understood
ThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
DiagnosticCriteria,Should,ShouldDescriptive
Criteria,Should,ShouldDescriptive
Avoid,AttributionOf,Causality
DiagnosticCriteria,Avoid,AttributionOfCausality
Criteria,Avoid,AttributionOfCausality
Wording,Should,ShouldEvidencebased
Wording,Should,FurthermoreShouldEvidencebased
Uncertainties,Direct,FutureResearch
Uncertainties,Direct,FutureClinicalResearch
Uncertainties,May,MayAddressed
Uncertainties,Direct,TheirImplications
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
Studies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDeposits
Studies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsFeatures
Studies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
Studies,Identified,ExtravascularFibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeatures
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsFeatures
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDeposits
Studies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,FibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,FibrinDeposits
Studies,Identified,DepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDeposits
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeatures
Carrying,FormOf,Fibrinogen
Carrying,FormOf,FibrinogenIncapable
Fibγ390396AMice,Were,Protected
Fibγ390396AMice,WereProtectedFrom,WeightGain
Carrying,MutantFormOf,FibrinogenIncapable
Fibγ390396AMice,WereProtectedFrom,HFDinducedWeightGain
Carrying,MutantFormOf,Fibrinogen
Fibγ390396AMice,HadDiminished,Systemic
Fibγ390396AMice,HadMarkedlyDiminished,Systemic
HepaticInflammation,IsWith,ReducedMacrophageCountsWithinWhiteAdiposeTissue
DirectThrombinInhibitor,IsWith,EstablishedObesity
Treatment,IsWith,Dabigatran
DirectThrombinInhibitor,IsIn,Mice
Pathologies,IsIn,ObesePatients
Pathologies,Targeting,Thrombin
It,Review,CurrentICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraft
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraft
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItEndeavor,Review,ICD11BetaDraft
It,Review,ICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraft
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfRevision
Patients,IsWith,Obesity
SinonasalDisease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,PoorAsthmaControl
SinonasalDisease,CanContributeTo,PoorAsthmaControl
LinkObesity,IsWith,IncreasedPrevalenceOfSinonasalDisease
Obesity,Is,Associated
Inflammation,Promotes,Progression
ObesityassociatedInflammation,Promotes,MetastaticProgression
ObesityassociatedInflammation,Promotes,Progression
Inflammation,Promotes,MetastaticProgression
Obesity,Causes,LungNeutrophilia
Increase,TranslatesTo,IncreasedBreastCancerMetastasis
Increase,TranslatesIn,GMCSF
Increase,IsIn,LungNeutrophils
Increase,TranslatesTo,BreastCancerMetastasis
Purpose,Affects,ResponseToCorticosteroidTreatment
Obesity,IsAssociatedWith,IncreasedSeverity
Purpose,Affects,ResponseToNasalCorticosteroidTreatment
Affects,ResponseTo,CorticosteroidTreatmentInAsthma
Obesity,Is,Associated
Affects,ResponseTo,NasalCorticosteroidTreatmentInAsthma
Purpose,Affects,Response
Affects,ResponseTo,NasalCorticosteroidTreatment
Purpose,Affects,ResponseToCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfDisease
Obesity,IsAssociatedWith,SeverityOfSinonasalDisease
Obesity,IsAssociatedWith,Severity
NasalCorticosteroidTreatment,IsIn,Asthma
Purpose,Was,Determine
Obesity,IsAssociatedWith,SeverityOfDisease
Affects,ResponseTo,CorticosteroidTreatment
Purpose,Affects,ResponseToNasalCorticosteroidTreatmentInAsthma
Obesity,IsAssociatedWith,IncreasedSeverityOfSinonasalDisease
SinonasalDiseaseSymptoms,IsWith,IncreasedAsthmaSeverity
Association,AreConsistentAcross,BMIGroups
WeightLoss,Is,ImportantlySufficient
WeightLoss,Reduce,SerumLevels
WeightLoss,Reduce,SerumLevelsOfGMCSF
WeightLoss,Is,Sufficient
WeightLoss,ReduceSerumLevelsIn,MouseModels
Response,Requires,Study
Response,Requires,FurtherStudy
Consideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,Management
SpecialConsideration,Is,Critical
Consideration,IsCriticalFor,EffectiveManagement
SpecialConsideration,IsCriticalFor,EffectiveManagementOfCancerProgression
Consideration,IsCriticalFor,Management
SpecialConsideration,IsCriticalFor,ManagementOfCancerProgression
SpecialConsideration,IsCriticalFor,EffectiveManagement
Consideration,IsCriticalFor,ManagementOfCancerProgression
Links,Are,Understood
ThrombinActivity,Underlies,ThromboembolicEvents
ElevatedThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
Links,Are,IncompletelyUnderstood
MechanisticLinks,Are,IncompletelyUnderstood
ElevatedThrombinActivity,Underlies,ThromboembolicEvents
MechanisticLinks,Are,Understood
ThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents
DiagnosticCriteria,Should,ShouldDescriptive
Criteria,Should,ShouldDescriptive
Avoid,AttributionOf,Causality
DiagnosticCriteria,Avoid,AttributionOfCausality
Criteria,Avoid,AttributionOfCausality
Wording,Should,ShouldEvidencebased
Wording,Should,FurthermoreShouldEvidencebased
Uncertainties,Direct,FutureResearch
Uncertainties,Direct,FutureClinicalResearch
Uncertainties,May,MayAddressed
Uncertainties,Direct,TheirImplications
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
Studies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDeposits
Studies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,ExtravascularDepositsAsDistinctFeatures
Studies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsAsFeatures
Studies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDeposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures
Studies,Identified,FibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
Studies,Identified,ExtravascularFibrinDepositsAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeatures
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,DepositsAsFeatures
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeaturesOfMice
Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDeposits
Studies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeaturesOfMice
Studies,Identified,FibrinDepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissue
ImmunohistochemicalStudies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice
Studies,Identified,FibrinDeposits
Studies,Identified,DepositsAsDistinctFeaturesOfMice
ImmunohistochemicalStudies,Identified,ExtravascularDeposits
ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeatures
ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,DepositsAsFeaturesOfMice
Studies,Identified,ExtravascularDepositsAsFeatures
Studies,Identified,Deposits
ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeatures
ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeaturesOfMice
ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeatures
Carrying,FormOf,Fibrinogen
Carrying,FormOf,FibrinogenIncapable
Fibγ390396AMice,Were,Protected
Fibγ390396AMice,WereProtectedFrom,WeightGain
Carrying,MutantFormOf,FibrinogenIncapable
Fibγ390396AMice,WereProtectedFrom,HFDinducedWeightGain
Carrying,MutantFormOf,Fibrinogen
Fibγ390396AMice,HadDiminished,Systemic
Fibγ390396AMice,HadMarkedlyDiminished,Systemic
HepaticInflammation,IsWith,ReducedMacrophageCountsWithinWhiteAdiposeTissue
DirectThrombinInhibitor,IsWith,EstablishedObesity
Treatment,IsWith,Dabigatran
DirectThrombinInhibitor,IsIn,Mice
Pathologies,IsIn,ObesePatients
Pathologies,Targeting,Thrombin
It,Review,CurrentICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraft
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraft
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfRevision
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
It,Review,ICD11BetaDraftForDefinitionOfOverweightRevision
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfOverweightRevision
ItEndeavor,Review,ICD11BetaDraft
It,Review,ICD11BetaDraftForDefinition
ItEndeavor,Review,ICD11BetaDraftForDefinition
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinition
ItEndeavor,Review,CurrentICD11BetaDraft
ItEndeavor,Review,ICD11BetaDraftForDefinitionOfRevision
It,Review,ICD11BetaDraftForDefinitionOfSubstantialRevision
ItImportantEndeavor,Review,ICD11BetaDraft
ItImportantEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfSubstantialRevision
It,Review,CurrentICD11BetaDraftForDefinitionOfRevision
Patients,IsWith,Obesity
SinonasalDisease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,AsthmaControl
Disease,CanContributeTo,PoorAsthmaControl
SinonasalDisease,CanContributeTo,PoorAsthmaControl
LinkObesity,IsWith,IncreasedPrevalenceOfSinonasalDisease
